Stay updated on PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Sign up to get notified when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:26.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no study data or page content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T10:55:25.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page footer shows a revision update from v3.4.0 to v3.4.1, indicating a minor software update. No user-facing content or study details were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T10:17:04.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Show glossary was added to the page. The page metadata now includes 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with a new revision tag v3.4.0 (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T04:57:31.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Site revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:05:23.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a dedicated Locations section showing Durham, North Carolina (Duke Cancer Center) and updated the page's revision to v3.3.3. Removed the HHS Vulnerability Disclosure link.
    Difference
    0.2%
    Check dated 2025-12-23T13:35:42.000Z thumbnail image

Stay in the know with updates to PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROCEED Trial: Pembrolizumab Combo in Esophago-gastric Clinical Trial page.